Skip to content

Ayurvedic management of Simple Allergic Conjunctivitis (Vataja Abhishyanda) with the help of Bilvadi Aschyotana with and without Haridrakhanda orally

Efficacy of Bilvadi Aschyotana with and without Haridrakhanda orally in the management of Simple Allergic Conjunctivitis (Vataja Abhishyanda) - An open labelled randomized comparative clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039321
Enrollment
30
Registered
2022-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

ITRA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients between 18 to 50 years of age. 2)Patients having Clinical signs and symptoms: Pricking Pain (Nistoda), Foreign body sensation (Sangharsha), Redness (Ragata), Dryness - feeling (Vishushka Bhava), Clean/Watery discharge (Achchasruta), Mild Chemosis (Alpa Shopha), Itching (Kandu), Burning Sensation (Daha).

Exclusion criteria

Exclusion criteria: 1)Patients below 18 years and above 50 years of age. 2)Patients having complications of corneal involvement like Marginal Corneal Ulcer, Dacryocystitis, Trachoma, Keratoconjunctivitis sicca, Vernal Keratoconjunctivitis, Giant papillary conjunctivitis, Atopic Keratoconjunctivitis. 3)All types of Conjunctivitis (Acute and Chronic) which are non-allergic in nature are excluded from the Study.

Design outcomes

Primary

MeasureTime frame
Changes in signs and symptoms of Simple Allergic Conjunctivitis (Vataja Abhishyanda) Timepoint: 2 Weeks

Secondary

MeasureTime frame
Changes in signs and symptoms of Simple Allergic Conjunctivitis (Vataja Abhishyanda) Timepoint: 4 Weeks

Countries

India

Contacts

Public ContactDr Deepak K Pawar

Institute of Teaching and Research in Ayurveda

drdeep29@gmail.com7737379173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026